These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1687486)

  • 1. Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
    Ebert D; Demling J
    Pharmacopsychiatry; 1991 Nov; 24(6):229-31. PubMed ID: 1687486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease.
    Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS
    Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of augmentation with moclobemide on symptoms of schizophrenia.
    Silver H; Aharon N; Hausfater N; Jahjah N
    Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Moclobemide in treatment of somatoform depression. A case report].
    Rütten J
    Fortschr Med; 1994 Mar; 112(7):95-6. PubMed ID: 8175100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F; Wolfersdorf M
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression: advances in drug treatment.
    Hopkins S
    Nurs Stand; 1993 Nov 24-30; 8(10):36. PubMed ID: 8297750
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Moclobemide].
    Gleiter C; Volz HP
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
    [No Abstract]   [Full Text] [Related]  

  • 16. New perspectives on the treatment of depression.
    Lapierre YD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():3. PubMed ID: 1394028
    [No Abstract]   [Full Text] [Related]  

  • 17. The Australian multicentre moclobemide trial.
    Stanton J
    Aust N Z J Psychiatry; 1993 Mar; 27(1):158. PubMed ID: 8481158
    [No Abstract]   [Full Text] [Related]  

  • 18. Moclobemide: a reversible inhibitor of monoamine oxidase type A.
    Baldwin D; Rudge S
    Br J Hosp Med; 1993 Apr 7-20; 49(7):497-9. PubMed ID: 8490690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
    Lipinski JF; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.